Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11239-020-02340-z http://scihub22266oqcxt.onion/10.1007/s11239-020-02340-z 33200333!7668406!33200333     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33200333&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Thromb+Thrombolysis 2021 ; 52 (1): 95-104 Nephropedia Template TP {{tp|p=33200333|t=2021. Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic |pdf=|usr=}}{{33200333}} gab.com Text Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic JO: J Thromb Thrombolysis http://www.kidney.de/pget.php?&tw=1&pmid=33200333 #FOAvip Although a reduction in hospital admissions of acute coronary syndromes (ACS) patients has been observed globally during the coronavirus disease 2019 (COVID-19) pandemic, clinical features of those patients have not been fully investigated. The aim of the present analysis is to investigate the incidence, clinical presentation, and outcomes of patients with ACS during the COVID-19 pandemic. We performed a retrospective analysis of consecutive patients who were admitted for ACS at our institution between March 1 and April 20, 2020 and compared with the equivalent period in 2019. Admissions for acute myocardial infarction (AMI) reduced by 39.5% in 2020 compared with the equivalent period in 2019. Owing to the emergency medical services (EMS) of our region, all time components of ST-elevated myocardial infarction care were similar during the COVID-19 outbreak as compared with the previous year's dataset. Among the 106 ACS patients in 2020, 7 patients tested positive for COVID-19. Higher incidence of type 2 myocardial infarction (29% vs. 4%, p = 0.0497) and elevated D-dimer levels (5650 mug/l [interquartile range (IQR) 1905-13,625 mug/l] vs. 400 mug/l [IQR 270-1050 mug/l], p = 0.02) were observed in COVID-19 patients. In sum, a significant reduction in admission for AMI was observed during the COVID-19 pandemic. COVID-19 patients were characterized by elevated D-dimer levels on admission, reflecting enhanced COVID-19 related thrombogenicity. The prehospital evaluation by EMS may have played an important role for the timely revascularization for STEMI patients. Twit Text FOAVip Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic ????J Thromb Thrombolysis http://www.kidney.de/pget.php?&tw=1&pmid=33200333 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33200333 #FOAvip English Wikipedia <ref>{{Cite pmid|33200333}}</ref> Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic #MMPMID33200333 Matsushita K; Hess S; Marchandot B; Sato C; Truong DP; Kim NT; Weiss A; Jesel L; Ohlmann P; Morel O J Thromb Thrombolysis 2021[Jul]; 52 (1): 95-104 PMID33200333show ga Although a reduction in hospital admissions of acute coronary syndromes (ACS) patients has been observed globally during the coronavirus disease 2019 (COVID-19) pandemic, clinical features of those patients have not been fully investigated. The aim of the present analysis is to investigate the incidence, clinical presentation, and outcomes of patients with ACS during the COVID-19 pandemic. We performed a retrospective analysis of consecutive patients who were admitted for ACS at our institution between March 1 and April 20, 2020 and compared with the equivalent period in 2019. Admissions for acute myocardial infarction (AMI) reduced by 39.5% in 2020 compared with the equivalent period in 2019. Owing to the emergency medical services (EMS) of our region, all time components of ST-elevated myocardial infarction care were similar during the COVID-19 outbreak as compared with the previous year's dataset. Among the 106 ACS patients in 2020, 7 patients tested positive for COVID-19. Higher incidence of type 2 myocardial infarction (29% vs. 4%, p = 0.0497) and elevated D-dimer levels (5650 mug/l [interquartile range (IQR) 1905-13,625 mug/l] vs. 400 mug/l [IQR 270-1050 mug/l], p = 0.02) were observed in COVID-19 patients. In sum, a significant reduction in admission for AMI was observed during the COVID-19 pandemic. COVID-19 patients were characterized by elevated D-dimer levels on admission, reflecting enhanced COVID-19 related thrombogenicity. The prehospital evaluation by EMS may have played an important role for the timely revascularization for STEMI patients. |*Percutaneous Coronary Intervention[MESH] |Acute Coronary Syndrome/diagnosis/epidemiology/*therapy[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Angina, Unstable/diagnosis/epidemiology/*therapy[MESH] |Biomarkers/blood[MESH] |COVID-19/diagnosis/epidemiology/*therapy[MESH] |Emergency Medical Services[MESH] |Female[MESH] |Fibrin Fibrinogen Degradation Products/analysis[MESH] |Humans[MESH] |Incidence[MESH] |Male[MESH] |Middle Aged[MESH] |Non-ST Elevated Myocardial Infarction/diagnosis/epidemiology/*therapy[MESH] |Patient Admission[MESH] |Retrospective Studies[MESH] |ST Elevation Myocardial Infarction/diagnosis/epidemiology/*therapy[MESH] |Time Factors[MESH] |Time-to-Treatment[MESH]Clinical features of patients with acute coronary syndrome during the (epmc).pdf DeepDyve Pubget Overpricing